SENSEX
NIFTY
GOLD
USD/INR

Weather

image 31    C

Economy News

The Economic Times

Economy / The Economic Times

details

AbbVie loses patent plea for Hep C drug

The Indian Patent Office has denied a secondary patent for AbbVie's Hepatitis C drug Maviret. This decision ensures continued access to affordable treatment for millions. The patent office refused the application after AbbVie failed to contest oppositions and chose to abandon it. This refusal prevents AbbVie from extending its patent monopoly by five years.

19 May 2026 12:53 am